Antibody

24개 · ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved24 programs
AntibodyCurated CoreFDANovo NordiskApproved

semaglutide (Ozempic / Wegovy, GLP-1, Wegovy, NN9535)

Type 2 diabetes, chronic weight management, CV risk reduction (T2D) · GLP-1 receptor

#GLP-1receptor#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 410Status Approved
AntibodyCurated CoreFDAEli LillyApproved

tirzepatide (Mounjaro / Zepbound, Mounjaro, Zepbound, LY3298176)

Type 2 diabetes, chronic weight management · GLP-1 / GIP receptor

#GLP-1GIPreceptor#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 269Status Approved
AntibodyCurated CoreFDAargenxApproved

efgartigimod (Vyvgart, ARGX-113, Vyvgart Hytrulo, efgartigimod alfa-fcab)

Generalized myasthenia gravis (AChR antibody positive), chronic inflammatory demyelinating polyneuropathy · FcRn (neonatal Fc receptor)

#FcRnneonatalFcreceptor#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 48Status Approved
AntibodyCurated CoreFDAAstraZenecaApproved

tezepelumab (Tezspire, AMG 157, MEDI9929, tezepelumab-ekko)

Severe asthma add-on maintenance, chronic rhinosinusitis with nasal polyps · TSLP (thymic stromal lymphopoietin)

#TSLPthymicstromallymphopoietin#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 47Status Approved
AntibodyCurated CorestaleRocheApproved

Tocilizumab (Tocilizumab)

Multiple Myeloma (MM); Multiple Myeloma Refractory · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Approved#BioJungboMoa-pick#Popular+5
Trials 161Status Recruiting
AntibodyLimited DatastaleRocheApproved

Omalizumab (Omalizumab)

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP); Chronic Rhinosinusitis (CRS) · Persistent Allergic Asthma

#PersistentAllergicAsthma#Antibody#Approved#Popular#monoclonal-antibody+4
Trials 89Status Active
AntibodyCurated CorestaleNovartisPhase 3

Ofatumumab (Ofatumumab)

Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma · Leukemia

#Leukemia#Antibody#Phase3#BioJungboMoa-pick#Popular+5
Trials 85Status Recruiting
AntibodyCurated CorestaleBelfast Health and Social Care …Approved

Golimumab (Golimumab)

Psoriatic Arthritis; Psoriasis · Chronic Nonbacterial Osteomyelitis

#ChronicNonbacterialOsteomyelitis#Antibody#Approved#BioJungboMoa-pick#Popular+5
Trials 80Status Discontinued
AntibodyLimited DatastaleUCB PharmaApproved

Certolizumab (Certolizumab)

Psoriasis; Atopic Dermatitis · Chronic Nonbacterial Osteomyelitis

#ChronicNonbacterialOsteomyelitis#Antibody#Approved#Popular#monoclonal-antibody+3
Trials 59Status Recruiting
AntibodyCurated CorestaleGSKApproved

Mepolizumab (Mepolizumab)

Chronic Rhinosinusitis With Nasal Polyps; Asthma; Eosinophilic · Asthma

#Asthma#Antibody#Approved#BioJungboMoa-pick#Popular+5
Trials 54Status Active
AntibodyLimited DatastaleRochePhase 2

Bendamustine + Rituximab (Bendamustine + Rituximab)

Marginal Zone Lymphoma(MZL) · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase2#Popular#monoclonal-antibody+3
Trials 52Status Recruiting
AntibodyLimited DatastaleNovartisPhase 3

Experimental: Secukinumab high dose (Experimental: Secukinumab high dose)

Chronic Severe Plaque-type Psoriasis · Chronic Severe Plaque-type Psoriasis

#ChronicSeverePlaque-typePsoriasi#Antibody#Phase3#monoclonal-antibody#Novartis
Trials 2Status Active
AntibodyCurated CorestaleRocheApproved

Xolair (Xolair)

Atopic Eczema; Atopic Dermatitis · Chronic Spontaneous Urticaria

#ChronicSpontaneousUrticaria#Antibody#Approved#BioJungboMoa-pick#monoclonal-antibody+3
Trials 2Status Active
AntibodyLimited DatastaleGerman CLL Study GroupPhase 2

Alemtuzumab i.v. (Alemtuzumab i.v.)

Chronic Lymphocytic Leukemia · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase2#monoclonal-antibody#German
Trials 1Status Active
AntibodyLimited DatastaleGerman CLL Study GroupPhase 2

Alemtuzumab s.c. (Alemtuzumab s.c.)

Chronic Lymphocytic Leukemia · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase2#monoclonal-antibody#German
Trials 1Status Active
AntibodyLimited DatastaleSanofiPreclinical

dupilumab, mepolizumab and benralizumab according to their marketing approval (Biologic treatments available in CRSwNP, Biologic treatments available in CRSwNP (dupilumab, mepolizumab and benralizumab according to their marketing approval))

Chronic Rhinosinusitis With Nasal Polyps · Chronic Rhinosinusitis With Nasal Polyps

#ChronicRhinosinusitisWithNasalPo#Antibody#Preclinical#monoclonal-antibody#Sanofi
Trials 1Status Recruiting
AntibodyLimited DatastaleBiocon Biologics UK LtdPhase 3

Bmab1200 (Bmab1200)

Moderate to Severe Chronic Plaque Psoriasis · Moderate to Severe Chronic Plaque Psoria

#ModeratetoSevereChronicPlaquePso#Antibody#Phase3#monoclonal-antibody#Biocon
Trials 1Status Active
AntibodyLimited DatastaleTaizhou Mabtech Pharmaceutical …Phase 3

CMAB007 (CMAB007)

Chronic Spontaneous Urticaria · Chronic Spontaneous Urticaria

#ChronicSpontaneousUrticaria#Antibody#Phase3#monoclonal-antibody#Taizhou
Trials 1Status Recruiting
AntibodyLimited DatastaleBiogenPhase 2

FCR + Lumiliximab (FCR + Lumiliximab)

Chronic Lymphocytic Leukemia · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase2#monoclonal-antibody#Biogen
Trials 1Status Discontinued
AntibodyLimited DatastaleJanssenPhase 3

Induction dose of (Induction dose of, Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin)

Hepatitis C, Chronic · Hepatitis C, Chronic

#HepatitisCChronic#Antibody#Phase3#monoclonal-antibody#HepatitisC+2
Trials 1Status Active

1 / 2 pages

← PreviousNext →